Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Presentation entities : Tonix pharmaceuticals holding corp. save search
Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 0.53%
H: 1.58%
C: -4.31%
presentation oxytocin pharmaceuticals spring meeting
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: -0.58%
H: 0.83%
C: -8.33%
presentation pharmaceuticals spring
Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in Fibromyalgia
Published: 2024-02-29 (Crawled : 13:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 3.69%
H: 0.21%
C: -2.53%
fibromyalgia congress presentation international pharmaceuticals
Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe
Published: 2023-10-11 (Crawled : 11:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: -0.54%
H: 4.61%
C: 2.55%
europe vaccine congress world presentation pharmaceuticals
Tonix Pharmaceuticals Announces Presentation of Non-Clinical Studies Supporting the Mechanism of TNX-1900 (Intranasal Potentiated Oxytocin) at the 2023 International Headache Congress
Published: 2023-09-18 (Crawled : 11:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: -7.51%
tnx-1900 congress presentation international pharmaceuticals
Tonix Pharmaceuticals Announces Poster Presentation Involving TNX-1700 in Preclinical Colorectal Cancer Models at the Seventh International Cancer Immunotherapy Conference 2023
Published: 2023-09-14 (Crawled : 11:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 1.12%
H: 2.21%
C: 0.1%
tnx-1700 conference presentation cancer international pharmaceuticals preclinical immunotherapy
Tonix Pharmaceuticals Announces Presentation of Data Supporting Development of Racemic and Single (S)-Isomer Tianeptine, Plastogen Anti-Depressants, at the American Society of Clinical Psychopharmacology Meeting
Published: 2023-06-05 (Crawled : 11:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 3.19%
H: 2.58%
C: 2.06%
presentation pharmaceuticals meeting
Tonix Pharmaceuticals Announces Presentation at the 2023 BIO International Convention
Published: 2023-05-30 (Crawled : 11:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 0.6%
H: 4.76%
C: -2.98%
presentation international pharmaceuticals
Tonix Pharmaceuticals Announces Poster Presentation at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
Published: 2023-05-25 (Crawled : 11:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: -1.69%
H: 1.06%
C: -2.86%
presentation pharmaceuticals meeting
Tonix Pharmaceuticals Announces Oral Presentation and Poster at the 5th International Congress on Controversies in Fibromyalgia
Published: 2023-03-23 (Crawled : 12:20) - biospace.com/
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 0.81%
H: 0.8%
C: -9.02%
fibromyalgia presentation international pharmaceuticals
Tonix Pharmaceuticals Announces Presentation at the Rare Disease Innovation and Partnership Summit
Published: 2023-03-16 (Crawled : 21:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 0.1%
H: 2.83%
C: 0.5%
partnership rare disease presentation innovation pharmaceuticals
Tonix Pharmaceuticals Announces Presentation of Clinical and Non-Clinical TNX-1900 Data at the Annual Headache Cooperative of the Pacific (HCOP) Winter Conference
Published: 2023-01-31 (Crawled : 13:00) - biospace.com/
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 0.91%
H: 2.7%
C: 0.9%
tnx-1900 pharmaceuticals conference presentation
Tonix Pharmaceuticals Announces Presentation of Licensed Antiviral Drug Technology at the 2nd Wnt & β-catenin Targeted Drug Development Conference
Published: 2023-01-26 (Crawled : 22:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 0.0%
H: 4.35%
C: 0.0%
pharmaceuticals drug conference antiviral technology presentation
Tonix Pharmaceuticals Presents Development Update on Potential Smallpox and Monkeypox Vaccine TNX-801 in an Oral Presentation at the World Vaccine and Immunotherapy Congress
Published: 2022-12-01 (Crawled : 12:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: -1.3%
H: 2.76%
C: -0.26%
tnx-801 pharmaceuticals monkeypox smallpox immunotherapy vaccine presentation potential update
Tonix Pharmaceuticals Announced Data from its Fully Human anti-SARS-CoV-2 Monoclonal Antibody Platform in an Oral Presentation at the World Antiviral Congress
Published: 2022-11-30 (Crawled : 13:00) - biospace.com/
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: -0.28%
H: 3.37%
C: 0.0%
pharmaceuticals antiviral antibody presentation platform
Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine and Immunotherapy Congress
Published: 2022-11-22 (Crawled : 13:20) - biospace.com/
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 1.21%
H: 1.26%
C: -0.03%
pharmaceuticals immunotherapy vaccine presentation
Tonix Pharmaceuticals Announces Oral Presentation at the World Antiviral Congress
Published: 2022-11-21 (Crawled : 13:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: -8.51%
pharmaceuticals antiviral presentation
Tonix Pharmaceuticals Announces Poster Presentation at Neuroscience 2022 by the Society for Neuroscience
Published: 2022-11-09 (Crawled : 12:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 2.8%
H: 0.0%
C: -7.13%
pharmaceuticals presentation
Tonix Pharmaceuticals Announces Presentation at the World Orphan Drug Congress USA
Published: 2022-07-06 (Crawled : 15:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: 0.0%
H: 0.59%
C: -5.39%
drug presentation
Tonix Pharmaceuticals Announces Presentation of Licensed Antiviral Drug Technology at the 4th Symposium of the Canadian Society for Virology
Published: 2022-06-08 (Crawled : 05:00) - globenewswire.com
TNXP | $0.16 1.91% 400K
|
Health Technology
|
| O: -0.88%
H: 4.44%
C: -6.22%
drug antiviral symposium technology presentation
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
ZCMD | $1.98 36.55% 27M
|
Commercial Services
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.304 25.57% 47M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.